Earnings release
Page 1
FOR IMMEDIATE RELEASE Media Contact Steve Brett , ( 224 ) 948-5353 media@baxter.com Investor Contact Clare Trachtman , ( 224 ) 948-3020 ● ● ● Baxter BAXTER REPORTS THIRD - QUARTER 2021 RESULTS Third - quarter revenue of $ 3.2 billion increased 9 % on a reported basis , 7 % on a constant currency basis and 6 % on an operational basis¹ Third - quarter U.S. GAAP earnings per share ( EPS ) of $ 0.89 increased 29 % ; Adjusted EPS of $ 1.02 increased 23 % Baxter expects full - year 2021 sales growth of 7 % to 8 % on a reported basis , 5 % to 6 % on a constant currency basis and 4 % to 5 % on an operational basis Baxter now expects full - year U.S. GAAP EPS of $ 2.82 to $ 2.86 and adjusted EPS of $ 3.58 to $ 3.62 DEERFIELD , III . , OCT . 28 , 2021 - Baxter International Inc. ( NYSE : BAX ) , a leading global medical products company , today reported results for the third quarter of 2021 . " Baxter's essential products , diverse portfolio and global scale continue to fuel our operations in 2021 , " said José ( Joe ) E. Almeida , chairman , president and chief executive officer . " This month marks Baxter's 90th anniversary . Our employees have been at the heart of our success for nine decades and remain as determined as ever to advance our Mission to Save and Sustain Lives . Our proposed acquisition of Hillrom , announced in September , represents an exciting new platform to further accelerate our impact , offering a broad array of new opportunities to advance innovation both across the continuum of care and around the world and meet the challenges of a rapidly evolving global healthcare landscape , while also creating significant value for all the stakeholders we serve . " 1 See tables to the press release for reconciliations of non - GAAP measures used in this press release to the corresponding U.S. GAAP measures . 1